Last Updated: September 28, 2026

Qilu Pharm Hainan Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for QILU PHARM HAINAN

QILU PHARM HAINAN has twenty approved drugs.

Summary for Qilu Pharm Hainan

US Patents:	0
Tradenames:	19
Ingredients:	19
NDAs:	20

Drugs and US Patents for Qilu Pharm Hainan

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Qilu Pharm Hainan	SUGAMMADEX SODIUM	sugammadex sodium	SOLUTION;INTRAVENOUS	215575-001	Jul 28, 2026	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Qilu Pharm Hainan	IMATINIB MESYLATE	imatinib mesylate	TABLET;ORAL	212135-002	Jun 21, 2022	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Qilu Pharm Hainan	DECITABINE	decitabine	INJECTABLE;INTRAVENOUS	212826-001	Apr 12, 2021	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Qilu Pharm Hainan	TADALAFIL	tadalafil	TABLET;ORAL	210420-001	Mar 26, 2019	AB1	RX	No	No		⤷ Start Trial				⤷ Start Trial
Qilu Pharm Hainan	OXALIPLATIN	oxaliplatin	INJECTABLE;INTRAVENOUS	204368-002	Jun 7, 2016	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Qilu Pharm Hainan	NICARDIPINE HYDROCHLORIDE	nicardipine hydrochloride	INJECTABLE;INJECTION	219608-001	Oct 28, 2025	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Qilu Pharm Hainan	CARBOPLATIN	carboplatin	INJECTABLE;INTRAVENOUS	219999-002	Feb 4, 2026	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.